StockNews.com Initiates Coverage on Brooklyn ImmunoTherapeutics (NYSE:BTX)

StockNews.com began coverage on shares of Brooklyn ImmunoTherapeutics (NYSE:BTX – Free Report) in a research report released on Friday. The brokerage issued a hold rating on the stock. Brooklyn ImmunoTherapeutics Trading Down 1.2 % Shares of BTX stock opened at $0.51 on Friday. The firm has a market capitalization of $30.24 million, a price-to-earnings ratio […]

Leave a Reply

Your email address will not be published.

Previous post StockNews.com Initiates Coverage on América Móvil (NYSE:AMX)
Next post StockNews.com Begins Coverage on Golden Minerals (NYSE:AUMN)